Integrin receptor antagonists
CA 2371604 A1 · Owner: Basf Aktiengesellschaft · Inventors: Graef, Claudia Isabella; Lauterbach, Arnulf; Zechel, Johann-Christian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to new compounds which bind to integrin receptors as , well as to their production, their use as integrin receptor antagonists and for the treatment of diseases, pharmaceutical preparations containing said compounds and pharmaceutical preparations containing at least one other active compound.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.